The Negative Pressure Wound Therapy (NPWT) competitive landscape is moderately consolidated, with a handful of global med-tech groups supplying the majority of hospital contracts while a long tail of regional specialists competes on price and local service. Global incumbents such as Acelity (now part of 3M), Smith & Nephew, and ConvaTec leverage broad reimbursement dossiers, multi-country regulatory filings, and centralized tendering relationships to secure high-volume accounts. Mid-tier and domestic manufacturers, particularly in China and India, offset limited clinical portfolios with 25–40 % lower pump-disposable bundles and faster on-site support, intensifying pricing pressure across the segment. Key competitive levers include portfolio breadth (portable vs. stationary pumps), biocompatibility of wound interfaces, battery life, and the speed of obtaining CE-mark or FDA 510(k) renewals; channel strength with home-care providers and group purchasing organizations is equally decisive.